$CLSN conference call 11 am today!
Celsion Corporation (NASDAQ:CLSN) shares climbed 6.30% to $1.03. The company, on April 23, provided a business update, including the latest findings from its analysis of clinical trial results for ThermoDox®, Celsion's proprietary heat-activated liposomal encapsulation of doxorubicin. Celsion is evaluating ThermoDox® in a Phase III clinical trial for primary liver cancer (the HEAT Study), a Phase II clinical trial for colorectal liver metastasis and a Phase II clinical trial for recurrent chest wall breast cancer.
Additionally, the company announced that it would hold a conference call to discuss first quarter 2013 results at 11:00 a.m. EDT on Thursday, May 9, 2013.
(0)
(0)NASDAQ DIP and RIP
Here is the best word that describes what i do here.
Intuitive;
means having the ability to understand or know something without any direct evidence or reasoning process.
I was born with it, I'm truly blessed!
Alway's searching for winners'
